Skip to main content
. 2009 May 15:183–272. doi: 10.1016/B978-0-443-07271-0.50006-9

Table 4.15.

Time course of irreversible disability in multiple sclerosis.

Study Time from onset of multiple sclerosis to reach selected levels of irreversible disability (years) Factors predictive of time from onset of multiple sclerosis to irreversible disability
Long-term natural history series with cross-sectional and/or some longitudinal assessment
R. Müller 1949; 1951 Not available
  • Observed data

  • Gender: male, shorter

  • Age at onset of multiple sclerosis: older, shorter

  • Initial symptoms: optic neuritis/brainstem, longer; motor/sensory, shorter

  • Initial course: progressive, shorter


  • Leibowitz et al 1964a; 1964b

  • Leibowitz and Alter 1970; 1973

Not available
  • Observed data

  • Gender: female, slightly shorter

  • Age at onset of multiple sclerosis: younger, longer

  • Initial symptoms: none

  • Initial course: progressive, shorter


Panelius 1969 Not available
  • Observed data

  • Gender: male, shorter

  • Age at onset of multiple sclerosis: younger, longer


S. Poser 1978 Not available
  • Observed data

  • Gender/age at onset of multiple sclerosis: none

  • Initial course: progressive, shorter


S. Poser et al 1982b Not available
  • Observed data

  • Age at onset of multiple sclerosis: older, slightly shorter

  • Initial symptoms: optic neuritis, longer

  • Initial course: progressive, shorter


  • V.A. Clark et al 1982

  • Detels et al 1982

  • Visscher et al 1984

Not available
  • Observed data

  • Logistic regression analysis

  • Gender: male, slightly shorter

  • Age at onset of multiple sclerosis: older, shorter

  • Residence: Los Angeles, shorter; Washington, longer

  • Initial symptoms: visual/speech/sensory, longer; motor/incoordination, shorter

  • Heat sensitivity: present, shorter

  • Early accumulation of disability: greater, shorter


Phadke 1987; 1990 Not available
  • Observed data

  • Gender: none

  • Age at onset of multiple sclerosis: younger, longer

  • Familial history of multiple sclerosis: negative, longer

  • Social class: higher, longer

  • Initial symptoms: optic neuritis/brainstem, longer; spinal cord/mixed, shorter

  • Duration of initial symptoms: shorter, longer

  • Initial course: progressive, shorter

  • Time from initial episode to second episode: longer, longer

  • Visual evoked potential latency: normal, longer

  • Cerebrospinal fluid findings: none


D.H. Miller et al 1992a Not available
  • Observed data

  • Gender: male, slightly shorter

  • Age at onset of multiple sclerosis: older, shorter

  • Initial symptoms: limb motor, shorter

  • Initial course: progressive, shorter

  • Number of relapses during the first 3 years of multiple sclerosis: none

  • Disability score at 5 years of multiple sclerosis: higher, shorter


Riise et al 1992 Not available
  • Multivariate linear regression analysis

  • All cases:

  • Age at onset of multiple sclerosis: older, shorter

  • Initial course of multiple sclerosis: progressive, shorter

  • Cases with a relapsing–remitting initial course of multiple sclerosis:

  • Gender: none

  • Age at onset of multiple sclerosis: older, shorter

  • Initial symptoms: pyramidal/cerebellar, shorter

  • Cases with a progressive initial course of multiple sclerosis:

  • Gender/age at onset of multiple sclerosis/initial symptoms: none


Kantarci et al 1998
  • Life table analysis

  • DSS 3: 11 (median)

  • DSS 6: 18 (median)

  • DSS 8: 28 (75th percentile)

  • Life table analysis

  • Cox regression analysis

  • End point = DSS 6

  • Gender: male, shorter

  • Age at onset of multiple sclerosis: older, shorter

  • Initial symptoms: motor/sphincter, shorter; optic neuritis, slightly longer; polyregional, none

  • Initial course: progressive, shorter

  • Number of relapses during the first 5 years of multiple sclerosis: greater, shorter


Myhr et al 2001
  • Life table analysis

  • DSS 6: 20 (median)

  • DSS 7: 15 (76th percentile)

  • Life table analysis

  • Cox regression analysis

  • End point = DSS 6

  • All cases:

  • Gender/familial history of multiple sclerosis/initial symptoms: none

  • Age at onset of multiple sclerosis: older, shorter

  • Initial course of multiple sclerosis: progressive, shorter

  • Cases with a relapsing–remitting initial course of multiple sclerosis:

  • Gender/age at onset of multiple sclerosis/familial history of multiple sclerosis/initial symptoms: none

  • Time from initial episode to second episode: longer, longer

  • Cases with a progressive initial course of multiple sclerosis:

  • Gender/age at onset of multiple sclerosis/familial history of multiple sclerosis/initial symptoms: none


Long-term natural history cohorts with longitudinal follow-up
United States Army Veterans World War II multiple sclerosis cohort
Kurtzke et al 1968a; 1970a; 1973; 1977 Not available
  • Observed data

  • End point = DSS 6 and 10

  • Age at onset of multiple sclerosis/initial symptoms: none

  • Socioeconomic status/month of onset of multiple sclerosis/year of onset of multiple sclerosis: none

  • Number of relapses during the first 5 years of multiple sclerosis: none

  • DSS score at 5 years of multiple sclerosis: higher, shorter

  • Symptoms at 5 years of multiple sclerosis: pyramidal/cerebellar, shorter

  • Number of affected functional systems at 5 years of multiple sclerosis: greater, shorter

Lyon, France, multiple sclerosis cohort
  • Confavreux 1977

  • Confavreux et al 1980

  • Life table analysis

  • DSS 4: 6 (median)

  • DSS 7: 18 (median)

  • Observed data

  • End point = DSS 4 and 7

  • Gender/initial symptoms: none

  • Age at onset of multiple sclerosis: younger, longer

  • Initial course: progressive, shorter

  • Time from initial episode to second episode: shorter, shorter

  • Number of episodes during the relapsing–remitting phase of multiple sclerosis: greater, longer

  • Time from initial episode to secondary progression: shorter, shorter

Confavreux et al 2000; 2003
  • Life table analysis

  • DSS 4: 8.4 [7.8–9.6]

  • DSS 6: 20.1 [18.1–22.5]

  • DSS 7: 29.9 [25.1–34.5] (median [95% confidence intervals])

  • Life table analysis

  • Cox regression analysis

  • End point = DSS 4, 6 and 7

  • All cases and cases with a relapsing–remitting initial course of multiple sclerosis:

  • Gender: female, longer

  • Age at onset of multiple sclerosis: younger, longer

  • Initial symptoms: optic neuritis, longer; long tracts, shorter

  • Initial course: progressive, shorter

  • Recovery from first episode: complete, longer

  • Time from initial episode to second neurological episode: shorter, shorter

  • Number of episodes during the first 5 years of multiple sclerosis: greater, shorter

  • Time from onset of multiple sclerosis to assignment of DSS 4: shorter, shorter

  • Cases with a progressive initial course of multiple sclerosis:

  • Gender: female, longer

  • All of the other clinical variables: none


Gothenburg multiple sclerosis cohort
  • Broman et al 1981

  • Runmarker and Andersen (1993)

  • Eriksson et al 2003

  • Life table analysis

  • DSS 6: 18 (median)

  • Life table analysis

  • Cox regression analysis

  • End point = DSS 6

  • All cases:

  • Initial course: progressive, shorter

  • Cases with a relapsing–remitting initial course of multiple sclerosis:

  • Gender: male, shorter

  • Age at onset of multiple sclerosis: younger, longer

  • Season of onset of multiple sclerosis/year of onset of multiple sclerosis/seen from onset: none

  • Initial symptoms: optic neuritis/sensory/monoregional, longer; long tracts, shorter

  • Recovery from first episode: complete, longer

  • Time from initial episode to second neurological episode:a none

  • Number of episodes during the first 5 years of multiple sclerosis:b none

  • Disability score at 5 years of multiple sclerosis:b higher, shorter

  • Number of affected functional systems at 5 years of multiple sclerosis:b greater, shorter

London, Ontario, multiple sclerosis cohort
Weinshenker et al 1989a; 1989b; 1991a
  • Life table analysis

  • DSS 3: 7.7 ± 0.4

  • DSS 6: 15.0 ± 0.3

  • DSS 8: 46.4 ± 0.1 (median ± SEM)

  • Life table analysis

  • Multivariate hierarchical analysis

  • End point = DSS 6 (and 8)

  • Gender: male, shorter

  • Age at onset of multiple sclerosis: younger, longer

  • Initial symptoms: optic neuritis, longer; cerebellar/insidious motor, shorter

  • Initial course: progressive, shorter

  • Seen from onset of multiple sclerosis: shorter

  • Time from initial episode to second episode:a shorter, shorter

  • Number of episodes during the first 2 years of multiple sclerosis: greater, shorter

  • Disability score at 2 years of multiple sclerosis: higher, shorter

  • Disability score at 5 years of multiple sclerosis: higher, shorter

  • Time from onset of multiple sclerosis to assignment of DSS 3:c shorter, shorter

Long-term history series from the therapeutic era
  • Amato et al 1999

  • Amato and Ponziani 2000

  • Life table analysis

  • DSS 4: 12.7

  • DSS 6: 14.1 (median)

  • Life table analysis

  • Cox regression analysis

  • Endpoint = DSS 4 and 6

  • Gender/age at onset of multiple sclerosis: none

  • Initial symptoms: pyramidal/cerebellar/sphincter/visual, shorter; sensory, longer

  • Number of affected functional systems at onset of multiple sclerosis: greater, shorter

  • Initial course: progressive, shorter

  • Recovery from first episode: incomplete, shorter

  • Time from initial to second neurological episode: longer, shorter

  • Number of episodes during the first 2 years of multiple sclerosis: none

  • Oligoclonal bands in cerebrospinal fluid at onset of multiple sclerosis: present, shorter

  • Brain MRI at onset of multiple sclerosis: suggestive, shorter

SD = standard deviation.

SEM = standard error of the mean.

a

Time to end point (DSS 6) estimated by the survival analysis using the second episode as starting point.

b

Time to end point (DSS 6) estimated by the survival analysis using five years after onset of multiple sclerosis as starting point.

c

Time to end point (DSS 6) estimated by the survival analysis using time of assignment of DSS 3 as starting point.

Data from the main series of the long-term course and prognosis of multiple sclerosis